BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 20338147)

  • 1. Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area.
    Ködmön C; Hollo V; Huitric E; Amato-Gauci A; Manissero D
    Euro Surveill; 2010 Mar; 15(11):. PubMed ID: 20338147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of extensively drug-resistant tuberculosis in Europe, 2003-2007.
    Devaux I; Manissero D; Fernandez de la Hoz K; Kremer K; van Soolingen D;
    Euro Surveill; 2010 Mar; 15(11):. PubMed ID: 20338144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control.
    Migliori GB; D'Arcy Richardson M; Sotgiu G; Lange C
    Clin Chest Med; 2009 Dec; 30(4):637-65, vii. PubMed ID: 19925959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.
    Fears R; Kaufmann S; Ter Meulen V; Zumla A;
    Tuberculosis (Edinb); 2010 May; 90(3):182-7. PubMed ID: 20382566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensively drug-resistant tuberculosis in california, 1993-2006.
    Banerjee R; Allen J; Westenhouse J; Oh P; Elms W; Desmond E; Nitta A; Royce S; Flood J
    Clin Infect Dis; 2008 Aug; 47(4):450-7. PubMed ID: 18616396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance data.
    Zignol M; Dara M; Dean AS; Falzon D; Dadu A; Kremer K; Hoffmann H; Hoffner S; Floyd K
    Drug Resist Updat; 2013 Dec; 16(6):108-15. PubMed ID: 24631052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensively drug-resistant (XDR) tuberculosis: an old and new threat.
    Fattorini L; Migliori GB; Cassone A
    Ann Ist Super Sanita; 2007; 43(4):317-9. PubMed ID: 18209265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and operational value of the extensively drug-resistant tuberculosis definition.
    Migliori GB; Besozzi G; Girardi E; Kliiman K; Lange C; Toungoussova OS; Ferrara G; Cirillo DM; Gori A; Matteelli A; Spanevello A; Codecasa LR; Raviglione MC;
    Eur Respir J; 2007 Oct; 30(4):623-6. PubMed ID: 17690121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study.
    Sharma SK; George N; Kadhiravan T; Saha PK; Mishra HK; Hanif M
    Indian J Med Res; 2009 Oct; 130(4):392-5. PubMed ID: 19942741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based surveillance of extensively drug-resistant tuberculosis in Shandong Province, China.
    Li X; Wang H; Jing H; Wang Y; Yu C; Wang J; Liu Z; Graviss EA; Ma X
    Int J Tuberc Lung Dis; 2012 May; 16(5):612-4. PubMed ID: 22410186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.
    Prasad R
    Indian J Tuberc; 2010 Oct; 57(4):180-91. PubMed ID: 21141336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged?
    Migliori GB; Sotgiu G; D'Ambrosio L; Centis R; Lange C; Bothamley G; Cirillo DM; De Lorenzo S; Guenther G; Kliiman K; Muetterlein R; Spinu V; Villar M; Zellweger JP; Sandgren A; Huitric E; Manissero D
    Eur Respir J; 2012 Mar; 39(3):619-25. PubMed ID: 22323578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug- and extensively drug-resistant tuberculosis in Africa and South America: epidemiology, diagnosis and management in adults and children.
    Schaaf HS; Moll AP; Dheda K
    Clin Chest Med; 2009 Dec; 30(4):667-83, vii-viii. PubMed ID: 19925960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012.
    van der Werf MJ; Ködmön C; Hollo V; Sandgren A; Zucs P
    Euro Surveill; 2014 Mar; 19(10):. PubMed ID: 24650865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood multidrug-resistant tuberculosis in the European Union and European Economic Area: an analysis of tuberculosis surveillance data from 2007 to 2015.
    Ködmön C; van den Boom M; Zucs P; van der Werf MJ
    Euro Surveill; 2017 Nov; 22(47):. PubMed ID: 29183553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.
    Vella V; Racalbuto V; Guerra R; Marra C; Moll A; Mhlanga Z; Maluleke M; Mhlope H; Margot B; Friedland G; Shah NS; Gandhi NR
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1170-5, i. PubMed ID: 21943840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-resistant tuberculosis: past, present, future.
    Chiang CY; Centis R; Migliori GB
    Respirology; 2010 Apr; 15(3):413-32. PubMed ID: 20337989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: current status and future prospects.
    Yew WW
    Kekkaku; 2011 Jan; 86(1):9-16. PubMed ID: 21401001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New treatment options for multidrug-resistant tuberculosis.
    Field SK; Fisher D; Jarand JM; Cowie RL
    Ther Adv Respir Dis; 2012 Oct; 6(5):255-68. PubMed ID: 22763676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensively drug-resistant tuberculosis: current challenges and threats.
    Jain A; Mondal R
    FEMS Immunol Med Microbiol; 2008 Jul; 53(2):145-50. PubMed ID: 18479439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.